Karmel Carothers, MD
Geriatric Medicine · Independence, MONPI 1427006543
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 330 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$736
- Novo Nordisk$579
- Lilly USA, LLC$532
- Pfizer$447
- AstraZeneca$430
- Boehringer Ingelheim$354
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,140100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $736 |
| Novo Nordisk | 44 | $579 |
| Lilly USA, LLC | 33 | $532 |
| Pfizer | 32 | $447 |
| AstraZeneca | 26 | $430 |
| Boehringer Ingelheim | 23 | $354 |
| Abbott | 17 | $332 |
| GSK | 23 | $319 |
| Amgen(2 entities) | 10 | $170 |
| Johnson & Johnson | 10 | $154 |
| Astellas Pharma US Inc | 7 | $123 |
| Sanofi-aventis U.S. LLC | 6 | $87 |
| Mylan Specialty L.p. | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Exact Sciences | 4 | $65 |
| Inspire Medical Systems, Inc. | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Boston Scientific | 1 | $43 |
| Viatris Specialty LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Novartis | 2 | $39 |
| Vertex | 1 | $38 |
| Cequr Corporation | 1 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Eisai Inc. | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Dynavax Technologies Corporation | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Corium, LLC | 1 | $15 |
| Bayer | 1 | $13 |
| Merck | 1 | $12 |
| Endogastric Solutions, Inc | 1 | $7 |
How this compares
$5,140 in reported general payments places this provider in the 90th percentile of 76 geriatric medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 150 | $226,762 |
| OzempicSemaglutide | 89 | $176,447 |
| EliquisApixaban | 88 | $93,548 |
| TrulicityDulaglutide | 42 | $91,817 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $82,419 |
| MounjaroTirzepatide | 46 | $63,250 |
| RybelsusSemaglutide | 35 | $57,789 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 138 | $38,870 |
| MyrbetriqMirabegron | 33 | $37,708 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 33 | $37,396 |
| TradjentaLinagliptin | 21 | $20,269 |
| XareltoRivaroxaban | 16 | $19,386 |
| Nurtec OdtRimegepant Sulfate | 11 | $18,369 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $17,656 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $17,648 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $354 | $247,031171 claims |
| Novo NordiskOzempic, Rybelsus | $579 | $234,236124 claims |
| GSKTrelegy Ellipta, Arexvy, Anoro Ellipta, Breo Ellipta | $319 | $171,349245 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $532 | $155,06788 claims |
| PfizerEliquis, Nurtec Odt, Abrysvo | $447 | $123,341137 claims |
| Astellas Pharma US IncMyrbetriq | $123 | $37,70833 claims |
| AstraZenecaFarxiga, Symbicort | $430 | $27,92536 claims |
| Johnson & JohnsonXarelto | $154 | $19,38616 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $87 | $17,65613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 76 geriatric medicine providers in Missouri.
Other geriatric medicine in Independence
- Marjon GillbanksIndependence$853
- John ConnollyIndependence$719
- Scott BowlinIndependence$21
- Srinath TadakamallaHarrisonville$82K
- Randall HalleyColumbia$18K
- Angela SanfordSaint Louis$15K
- Madhu SahaiSikeston$6K
- John MorleySt Louis$6K
- William KnappFlorissant$5K
- Ellen BinderSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.